A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
manufactures and sells health care products. Major lines by segment: Consumer (baby care, nonprescription drugs, sanitary protection, and skin care), Med. Device & Diag. (wound closures, minimally invasive surgical instruments, diagnostics, orthopedics, and contact lenses), and Pharmaceutical (contraceptives, psychiatric, anti-infective, and dermatological drugs).
Very active on making acquisitions of other companies which is a very good sign during a recession, could see some stall in the earnings growth this year due to high competition for the analgesic drug dragesic and the schizophrenia drug Respardil. This will more then likely not hurt the stock price to muc as estimates of an economic rebound coming late 09, early 10 will have people buying back this stock in a hurry
JNJ makes roughly 7.5 billion a year that it will continue to use in paying dividens, buying back stock and making more acquisitions. The are as close to a monopoly as you can get in America.